Skip to main content
. Author manuscript; available in PMC: 2014 Mar 17.
Published in final edited form as: J Am Geriatr Soc. 2012 Feb 8;60(3):455–461. doi: 10.1111/j.1532-5415.2011.03854.x

Table 2.

Anti-Osteoporosis Medication (AOM)* Use in Women with Incident Fracture According to Fracture Location (N = 1,075)

Fracture Location n n (%)
 P-Value
No Current AOM (n = 888) Current AOM (n = 187)
Spine 55 32 (4.0) 23 (16) <.001
Hip 76 56 (6.9) 20 (14) .005
Wrist 230 198 (24) 32 (22) .56
Other nonvertebral† 749 622 (70) 127 (68) .56
Single 953 809 (91) 144 (77) <.001
Multiple 122 79 (8.9) 43 (23)
*

Estrogen, selective estrogen receptor modulators, bisphosphonates, calcitonin, parathyroid hormone, and strontium.

†

Clavicle, upper arm, rib, pelvis, ankle, upper leg, lower leg, foot, hand, shoulder, knee, elbow, sternum, or multiple fractures of unknown type.